⌘K
t
BSF Enterprise PLC announced on 23 May 2025 that it has amended the warrant instrument issued on 26 April 2022. The amendment for 12,270,217 warrants reduces the exercise price from 15p to 7.5p and extends the exercise term by 2 years, setting the new expiry date to 17 May 2027.
| Date | 23 May 2025 |
| Time | 07:00:06 |
| Category | Miscellaneous |
| ID | 8777J |
London, 23 May 2025
BSF Enterprise PLC
15p Warrants Amended
BSF Enterprise PLC (LSE:BSFA) (the "Company") a leading innovator in tissue-engineered materials is pleased to announce that it has agreed to amend the warrant instrument issued on 26 April 2022 ("Warrant Instrument") constituting warrants to subscribe for 12,270,217 ordinary shares of one penny each in the capital of the Company at 15p for a period of 3 years (the "Warrants").
The Warrant Instrument has been amended to reduce the exercise price for each of the Warrants from 15p to 7.5p and extend the exercise term by 2 years, to expire on 17 May 2027.
The amendment will not affect any other provisions of the Warrants or any other rights or obligations of the warrantholders.
Contact Information For further information, please visit: www.bsfenterprise.com
For further enquiries, please visit www.bsfenterprise.com or contact:
|
BSF Enterprise PLC |
|
|
Geoff Baker - Executive Director Che Connon - CEO & Director |
|
|
|
|
|
Shard Capital (Broker) |
|
|
Damon Heath Isabella Pierre |
0207 186 9000 0207 186 9927 |
|
|
|
About BSF Enterprise PLC
BSF Enterprise PLC (BSF) develops and commercialises cutting-edge tissue-engineered solutions, including lab-grown leather, cultivated meat, and corneal repair technologies. By leveraging its proprietary scaffold-free platform, BSF aims to deliver sustainable alternatives to traditional materials and meet global demand for environmentally responsible innovations.